111, Inc.: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on May 14, 2024 and accepted by EDGAR at May 14, 2024, 08:49 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $2.11bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $1.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | CNY 849.0m | us-gaap:GrossProfit |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$49.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $2.8m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $35.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | −$49.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$0.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$0.33 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 168,609,128 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$63.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $1.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-12-31 | $85.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $413.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $435.1m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $386.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $396.2m | us-gaap:Liabilities |
| Short-term borrowings | At period end2023-12-31 | $47.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | −$82.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-24-060922. Last ingested by Listed: Oct 26, 2026, 06:07 ET. Listed shows no prices and gives no investment advice.